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Abstract 
 
Nicotine Replacement Therapy (NRT) is an effective 
medication to help patients quit smoking tobacco. 
Yet, 18% of adults in the United States still smoke 
cigarettes. With advancements in health technology 
and improved features within electronic health 
record (EHR) systems, it is crucial to understand how 
differences in EHR features influence the prescribing 
of NRT. We conducted a cross-sectional study of 174 
primary care practices to better understand how 
EHR features, including drug reference databases in 
EHRs, were associated with NRT prescribing at a 
practice level. Regression models were created to 
understand NRT prescribing patterns among clinics 
with varying EHR features and found that practices 
using an EHR with a drug reference database were 
2.3 times more likely to view NRT as a high priority 
for treating smokers. Use of NRT in primary care 
differs significantly in relation to the capability of a 
clinic’s technology. Clinics with more EHR features, 
specifically EHR drug reference databases, favored 
NRT. Our study suggests that pharmacotherapy could 
become the preferred activity in smoking cessation 
treatment, as EHR-integrated drug reference 
database prevalence increases.  
 
1. Introduction  
 
Smoking is the number one preventable 
cause of premature death in the United States. While 
prevalence of tobacco use has declined over the past 
few decades, 17% (40 million people) of Americans 
are still addicted to smoking cigarettes.[17] Of those 
that do attempt to quit, only 5% will successfully 
maintain cessation at 6 months.[1] Helping smokers 
quit is the most important action that healthcare 
providers can take to improve the length and quality 
of life of these patients.[8] Since the majority of 
smokers (70%) see a healthcare provider at least once 
annually,[3, 6, 7, 13, 22] the point of care encounter 
is an ideal time to address smoking cessation. 
Nicotine Replacement Therapy (NRT) is defined as a 
smoking cessation treatment where nicotine from 
tobacco is replaced by other forms of pharmaceutical 
nicotine, such as through the skin with patches, 
inhalation of sprays, or consumed using gum or 
lozenges.[21] NRT is an effective method for 
smoking cessation[20] and thus, Clinical Practice 
guidelines recommend NRT to assist patients in their 
cessation efforts.[4] However, despite the Clinical 
Practice guidelines, only a small percentage of 
smokers receive NRT from their healthcare 
provider.[11] 
Electronic Health Records (EHRs) offer an 
opportunity to increase quality of care delivered at 
the system-level in outpatient settings. EHRs, which 
are now common in outpatient settings,[12] provide a 
means to improve cessation through effective 
documentation and tracking of clinical practice. For 
example, physician reminder systems incorporated 
into EHRs have demonstrated their efficiency in 
various settings to increase preventive service.[2, 16]  
Recent Meaningful Use regulations through the EHR 
Incentive Program administered by the Centers for 
Medicare & Medicaid Services (CMS) mandate 
health professionals and physicians electronically 
screen for tobacco use in their patients.[18] Under 
such guidelines, EHRs offer the opportunity for 
health care providers and patients to be better able to 
coordinate care and share health information, 
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particularly regarding preventable medical 
conditions. However, the implementation of EHRs in 
the United States is still varied.[9] Of those practices 
with EHR systems, there are wide variations in the 
implementation and adherence to standard prevention 
guidelines.[23]  
The potential to show that EHR-integrated 
features improve smoking cessation treatment has 
been limited thus far.[15] EHR-integrated Electronic 
Drug Reference Databases provide healthcare 
providers with critical information at the point-of 
care[14] and can be used in congruence with other 
EHR-integrated decision support tools to assist in 
NRT prescribing.  To the authors’ knowledge, this is 
the first study to investigate the association of 
electronic health record features, specifically 
electronic drug reference databases integrated into 
EHRs, with the prescription of NRT. 
 
2. Methods  
 
2.1. Study Design  
In preparation for a national technology-
assisted clinical microsystem tobacco control 
implementation trial,[10] we conducted a cross-
sectional survey of primary care practices. This 
survey assessed both EHR implementation and 
tobacco control activities.  This study was reviewed 
and approved by the University of Massachusetts 
Medical School Institutional Review Board. 
 
2.2. Setting and Sample  
One hundred seventy-four medical practices, 
nationwide, were recruited from a registered database 
of internal medicine and family practice clinics.  
These practices were recruited for two federally-
funded pragmatic trials evaluating Decide2Quit.org, a 
patient-centered web-assisted tobacco intervention 
and QUIT-PRIMO (Quality Improvement in Tobacco 
Provider Referrals & Internet-delivered Microsystem 
Optimization).[10] For our study, we utilized the 
baseline practice-level surveys from both of the 
aforementioned trials in our analyses. 
 
2.3. Data Collection 
A mailed survey of five pages was 
completed by each practice.  Practices were asked to 
identify a single point of contact (physician or nurse), 
who would complete the data collection for the 
practice.  The survey contained questions about clinic 
characteristics and about patient tobacco assessment 
and treatment activities. Questions were formatted as 
either dichotomous closed-ended questions or 
questions with a Likert scale response. Practice 
respondents identified their role and provided 
information related to perceived barriers, use of tools, 
and subsequent guideline-concordant tobacco control 
activities.  Practices were also asked to report their 
current level of EHR adoption. 
Independent Variables.  Electronic Health 
Record (EHR) utilization was captured by the 
baseline survey using a yes/no response.  
Additionally, we asked if electronic decision support 
systems or drug reference databases were used.  
These questions also had dichotomous response 
categories. To estimate patient panel age, we asked 
practices to report the approximate percentage of 
patients in the clinic that fall in following age ranges: 
1-18, 19-44, 45-64, 65 or older. To estimate patient 
panel race, we asked practices to report the 
approximate percentage of patients in their clinic that 
are the following races: White, Black, Hispanic, 
American Indian, Asian or Pacific Islander, and 
Other (please specific). To estimate patient panel 
insurance, we asked practices to report the 
approximate percentage of patient care revenue 
received from the following sources: Captitated or 
prepaid basis (commercial), capitated or prepaid 
bases (state or federal), fee for service third party 
payer, self-pay, charity care, other (please specify).  
Additional characteristics of the clinics were 
ascertained by asking approximately how many 
patients are seen at the practice per week?  What the 
estimated daily number of incoming calls to the 
practice from patients was? How many computers 
with Internet access does this practice have? And if 
the practices were internal medicine clinics or family 
medicine practices.  
Dependent Variable.  The dependent 
variable of interest was if prescribing NRT was 
included in tobacco control activities.  Participants 
were asked to rate their agreement with the statement 
below using a five-point Likert scale ranging from 
strongly agree to strongly disagree to form our 
dependent variable:  
“Prescribing nicotine replacement therapy for 
patients ready to quit IS a high priority for our 
practice.”  
 
2.4. Statistical Analyses 
We used a logistic regression model to 
evaluate what technological capabilities were 
associated with a prioritization of NRT.  
For the dependent variable, viewing 
prescribing of NRT as a high priority,, the 5-point 
Likert scale results were recoded into a dichotomous 
variable due to a low percentage of answers in some 
response categories. We placed practices that 
strongly agreed and agreed with the statement in one 
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group and the remainder of the practices in a second 
group. 
 
3. Results 
 
3.1. NRT Emphasis 
Of the 174 practices who returned the 
practice-level surveys, 106 viewed NRT as a high 
priority while 68 did not. We compared the 
characteristics of practices that saw NRT as a priority 
vs. those that did not. We found no statistically 
significant differences in patient population, payer 
mix, clinic volume, and practice type. Comparisons 
are shown in Table 1. 
 
Table 1. 
 
 
NRT 
not a 
Priority 
n=68 
NRT a 
Priority 
n=106 
Sig.  
(2-
tailed) 
Patient Panel Age (%) 
  
 
1-18 Years 9.6 9.7 0.92 
19-44 Years 28.5 27.6 0.61 
45-64 Years 33.6 34.7 0.50 
65+ Years 28.8 27.9 0.68 
Patient Panel Race (%)    
White 72.7 72.2 0.59 
Black 19.9 21.6 0.60 
Hispanic 12.3 15.4 0.30 
Other Race 7.8 6.1 0.34 
Patient Panel Insurance 
(%)    
Capitated or Prepaid 
Commercial 16.5 20.6 0.23 
Capitated or Prepaid 
State or Federal 30.6 29.2 0.67 
Fee for Service 40.2 37.4 0.55 
Self-Pay 9.8 9.2 0.79 
Charity Care 3.9 4.4 0.75 
Other Insurance 1.0 2.3 0.44 
Clinic Characteristics 
(mean)     
Visits per week per 
provider 98.4 102.3 0.63 
Daily calls from patients 54.8 61.6 0.50 
Number of computers 
per practice   4.9 4.4 0.45 
Type of Practice (%) 
Internal Medicine 
Family Medicine 
 
50.0 
50.0 
 
40.0 
60.0 
 
0.14 
 
3.2. Logistic Regression 
The logistic regression model (Table 2) 
including having any Electronic health record, having 
an EHR with a decision support system, and having 
an EHR that includes and drug reference database.  
This model shows that practices with a drug 
reference database were 2.34 (p=0.03) times more 
likely to prioritize NRT than practices without a drug 
reference database included in the EHR. In addition 
to this primary model, we conducted sensitivity 
analyses including characteristics in Table 1, with no 
change in the main effect, and there were no other 
significant associations. 
 
Table 2. Logistic Regression predicting 
factors associated with viewing NRT as a 
high priority. 
 
  
Odds 
Ratio B S.E. Sig. 
Clinic has Decision 
Support System 
integrated with the EHR 
1.8 0.58 0.47 0.22 
Clinic has any 
Electronic Health 
Record 
1.0 0.01 0.36 0.97 
Clinic has Drug 
Reference Database 
integrated with the EHR 
2.3 0.85 0.38 0.03 
Constant 0.8 -0.24 0.64 0.71 
Note: Sensitivity analyses included models adjusting for 
characteristics in Table 1. No other factors were significant. 
 
4. Discussion 
 
In a cross-sectional study of 174 primary 
care practices recruited from our nationwide study, 
we found that practices with electronic drug reference 
databases integrated into electronic health record 
systems were more likely to prioritize NRT than 
practices without drug reference databases. Our 
findings indicate that drug reference databases are a 
critical component of the EHR because they notify 
providers of important health interventions, in this 
case NRT. Drug reference databases have the 
potential to be an integral part of efficient decision 
support for health behavior outcomes. Despite 
research that suggests a combination of NRT and 
therapy in smoking cessation treatment,[19] current 
EHR decision support systems primarily focus on 
medication, especially EHRs with a drug reference 
database. Providers using EHRs and drug reference 
databases may get prompts and support in 
recommending medicinal interventions, but not 
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evidence-based behavioral interventions. Future 
considerations for software rollouts should integrate 
decision support tools focusing on behavioral 
strategies with drug reference databases. 
As EHRs continue to be implemented 
throughout the nation, it is likely that the benefits of 
more complex system components will be actualized. 
EHR comprehensive decision support for smoking 
cessation has the potential to increase primary 
prevention and the quality of life of patients by 
addressing all five stages of the 5 A’s of smoking 
cessation guidelines:  ask, advise, assess, assist, and 
arrange.[5] Given the frequency in which individuals 
visit their primary care providers, EHRs present an 
effective mode in which to support tobacco cessation 
among patient populations.  
This study was limited to a small sample of 
clinics participating in a smoking cessation study, 
and therefore may not be generalizable to the broader 
population. It should also be noted that EHR 
capabilities and the smoking cessation treatment 
information were self-reported by the practices, 
which introduces the risk of misclassification bias. 
Still, these findings provide a foundation in which to 
generate further hypotheses, interventions, and 
research in the realm of EHRs and practice-based 
smoking cessation efforts.  
 
5. Conclusion 
  
Use of NRT in primary care differs 
significantly in relation to the capability of a clinic’s 
use of technology. Clinics with more technological 
capabilities, specifically those with drug reference 
databases, favored NRT. Our study suggests that 
pharmacotherapy could become the preferred activity 
in smoking cessation treatment, as drug reference 
database prevalence increases. Past studies have 
looked at EHRs as a general tool to support smoking 
cessation, and not specific features, and systematic 
reviews have noted that only weak evidence exists.  
Thus, our work adds to literature by identify drug 
databases as the specific feature related to treatment 
with NRT. Future studies should attempt to address 
how technology can be used more effectively in 
smoking cessation and other preventive activities in 
larger patient populations.  
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